Sterling Accuris’ revenue surpasses Rs 200 Cr in FY25, turns EBITDA positive

Share via:


Diagnostic and pathology services chain Sterling Accuris Diagnostics managed 22% year-on-year growth in its operating scale during the fiscal year ending March 2025. Significantly, the Ahmedabad-based firm also narrowed its losses and turned EBITDA positive during the last fiscal year.

The company’s revenue from operations grew to Rs 198 crore in FY25 from Rs 162 crore in FY24, its consolidated financial statements sourced from the Registrar of Companies (RoC) show.

sterlingaccuris graph

Founded in 2014, Sterling Accuris Diagnostics offers over 2,000 tests through around…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Sterling Accuris’ revenue surpasses Rs 200 Cr in FY25, turns EBITDA positive


Diagnostic and pathology services chain Sterling Accuris Diagnostics managed 22% year-on-year growth in its operating scale during the fiscal year ending March 2025. Significantly, the Ahmedabad-based firm also narrowed its losses and turned EBITDA positive during the last fiscal year.

The company’s revenue from operations grew to Rs 198 crore in FY25 from Rs 162 crore in FY24, its consolidated financial statements sourced from the Registrar of Companies (RoC) show.

sterlingaccuris graph

Founded in 2014, Sterling Accuris Diagnostics offers over 2,000 tests through around…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

AURO University Proudly Hosts Its 13th Convocation Ceremony by...

Surat (Gujarat) , December 29: AURO University proudly...

Zepto’s IPO plans: A look at the journey so...

Quick commerce platform Zepto, which is expected to...

National Healthcare Leadership Forum 2025 Highlights the Great Healthcare...

National Healthcare Leadership Forum 2025 Highlights the Great...

Popular